Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement

Bone Marrow Transplantation
T KarlasGeorg-Nikolaus Franke

Abstract

Allogeneic hematopoietic stem cell transplantation is the only curative option for a variety of diseases. Despite advances, it is associated with considerable morbidity and mortality, often involving liver complications. Liver disease can be characterized using ultrasound-based liver stiffness measurement. To assess its prognostic value, consecutive patients undergoing allogeneic hematopoietic stem cell transplantation were prospectively evaluated in a single-center study. Endpoints included liver event-free survival and all-cause mortality at 1 year. Competing risk and Cox-regression were used for analysis. We evaluated 106 patients (42 female, age 57) and observed 33 life-threatening events (14 died) including 16 liver complications at 100 days. At 1 year, 36 patients had died, 20 with disease relapse. The hazard ratios for liver-related complications at 100 days were 3.2 (95% CI: 1.8-14.6, p = 0.0022) and 4.4 (95% CI: 1.6-11.9, p = 0.0042) for elevated transient elastography (n = 11) and shear-wave velocity (n = 31), respectively. Results were analogous for all-cause mortality at 1 year. Prior stem cell therapy and elevated gamma glutamyltransferase were also associated with outcome. This demonstrates that elastography is a ...Continue Reading

References

Apr 28, 2006·The New England Journal of Medicine·Edward A Copelan
Apr 8, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·George B McDonald
Nov 16, 2011·Critical Care : the Official Journal of the Critical Care Forum·Alexander KochFrank Tacke
Aug 18, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jérôme BoursierUNKNOWN Multicentric Group from ANRS/HC/EP23 FIBROSTAR Studies
Jan 22, 2013·Journal of Hepatology·Annalisa Berzigotti, Laurent Castera
Feb 11, 2014·Ultraschall in der Medizin : Organ der Deutschen Gesellschaft für Ultraschall in der Medizin, [der] Österreichischen Gesellschaft für Ultraschall in der Medizin, [der] Schweizerischen Gesellschaft für Ultraschall in Medizin und Biologie·T KarlasV Keim
Jun 18, 2014·The American Journal of Gastroenterology·Naga P ChalasaniUNKNOWN Practice Parameters Committee of the American College of Gastroenterology
Aug 16, 2014·Journal of Multivariate Analysis·Ruosha Li, Limin Peng
Apr 26, 2015·Journal of Hepatology·UNKNOWN European Association for Study of Liver, UNKNOWN Asociacion Latinoamericana para el Estudio del Higado
Apr 4, 2016·Journal of Hepatology·Eric TrépoPierre Nahon
Apr 12, 2016·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver (EASL)UNKNOWN European Association for the Study of Obesity (EASO)
Jan 14, 2017·World Journal of Gastroenterology : WJG·Sebastian Mueller
Apr 14, 2017·Ultraschall in der Medizin : Organ der Deutschen Gesellschaft für Ultraschall in der Medizin, [der] Österreichischen Gesellschaft für Ultraschall in der Medizin, [der] Schweizerischen Gesellschaft für Ultraschall in Medizin und Biologie·Christoph F DietrichMaja Thiele
Nov 22, 2017·Hepatic Medicine : Evidence and Research·Francesca Virginia BruschiMichael Trauner
May 8, 2018·Blood·Alexander I SalterStanley R Riddell
May 29, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mutsumi NishidaTakanori Teshima
Jun 22, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Christopher StrouseWael Saber
Aug 5, 2018·Ultrasound in Medicine & Biology·Christoph F DietrichYi Dong

❮ Previous
Next ❯

Citations

Sep 11, 2021·Zeitschrift für Gastroenterologie·Thomas Karlas, Georg-Nikolaus Franke

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
genotyping
MDS

Software Mentioned

cmprsk
R

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.